MMP9 and rheumatoid arthritis: All together, these data suggest that Col3-4 immunoreactivity in the synovial tissue of patients with RA results from the degradation of type III and type IV collagens by MMP-9 -and possibly other proteinases- which is over-expressed in destructive fibroblasts of the synovial lining layer [25].